| GLASS: Global Lorlatinib for ALK (+) and ROS1 (+) retrospective Study: real world data of 123 NSCLC patients N Peled, R Gillis, S Kilickap, P Froesch, S Orlov, E Filippova, U Demirci, ... Lung Cancer 148, 48-54, 2020 | 27 | 2020 |
| A new prognostic index in young breast cancer patients H Demir, A Demirci, S Karagöz Eren, İ Beypınar, SE Davarcı, M Baykara College of Physicians and Surgeons Pakistan, 2022 | 21 | 2022 |
| Intravenous chemotherapy adherence of cancer patients in time of covid-19 crisis I Beypinar, U Muslih International Journal of Hematology and Oncology 33 (1), 133-138, 2020 | 13 | 2020 |
| Efficacy and safety of trastuzumab emtansine in HER2 positive metastatic breast cancer: real-world experience A Bahçeci, S Paydaş, N Ak, F Ferhatoğlu, PM Saip, G Seydaoğlu, M Bilici, ... Cancer investigation 39 (6-7), 473-481, 2021 | 10 | 2021 |
| Are preoperative serum CA15-3 levels different in breast cancer subgroups? M Araz, I Beypinar, S Kazan, F Inci, M Celiker, M Uysal Current problems in cancer 43 (2), 115-122, 2019 | 10 | 2019 |
| The relationship between EGFR mutation and metastasis pattern in lung adenocarcinoma I Beypinar, H Demir, M Araz, M Uysal Journal of Oncological Sciences 5 (2), 65-69, 2019 | 7 | 2019 |
| Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter … M Araz, M Karaagac, L Korkmaz, L Koral, F Inci, I Beypinar, M Uysal, ... Cancer Chemotherapy and Pharmacology 83, 1091-1097, 2019 | 7 | 2019 |
| Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes E Esin, B Oksuzoglu, A Bilici, I Cicin, O Kostek, MA Kaplan, S Aksoy, ... Cancer chemotherapy and pharmacology 83, 131-143, 2019 | 6 | 2019 |
| Prognostic role of pre-operative serum ferritin level in stage 2 colon cancer H Demir, İ Beypınar, S Urvay, SE Davarcı, M Baykara Verduci, 2021 | 5 | 2021 |
| The effect of the body composition to prognosis in young breast cancer patients I Beypinar, K Furkan, H Demir Akdeniz Tıp Dergisi 7 (3), 385-391, 2021 | 3 | 2021 |
| The view of Turkish oncologists regarding MSI status and tumor localization in stage II and III colon cancer I Beypinar, H Demir, M Araz, M Baykara, NF Aykan Journal of Gastrointestinal Cancer, 1-7, 2020 | 3 | 2020 |
| P1. 14-15 Lorlatinib in ALK-or ROS1-positive non-small cell lung cancer patients: experience from an early access program in Turkey S Kilickap, U Demirci, F Bugdayci, D Tural, T Korkmaz, S Paydas, ... Journal of Thoracic Oncology 14 (10), S558-S559, 2019 | 3 | 2019 |
| The compliance with antiemetic guidelines of Turkish medical oncologists. A survey study of Turkish Oncology Group M Araz, M Karaagac, L Korkmaz, I Beypinar, M Uysal Current Problems in Cancer 43 (4), 344-353, 2019 | 3 | 2019 |
| The Effect of the Prognostic Nutritional Index on Chemoradiotherapy Response in Lung Cancer H DEMİR, İ BEYPINAR, M BAYKARA | 3 | |
| Real-life analysis of efficacy and safety of everolimus plus exemestane in hormone receptor-positive, human epidermal growth factor receptor-2-negative metastatic breast cancer … A Bilici, M Uysal, S Menekse, S Akin, F Yildiz, M Turan, S Sezgin Goksu, ... Cancer Investigation 40 (2), 199-209, 2022 | 2 | 2022 |
| Microsatellite instability (MSI) in endometrial cancer; frequency and prognostic significance A Küçük, H Demir, Ç Özdemir, İ Beypınar, M Baykara, DT Arıöz Derman Medical Publishing, 2022 | 2 | 2022 |
| The real-life data of BRAF mutation on the treatment of colorectal cancer: a TOG study I Beypinar, H Demir, A Sakin, BY Taskoylu, T Sakalar, Y Ergun, ... Journal of Gastrointestinal Cancer 52, 932-939, 2021 | 2 | 2021 |
| The effect of COVID-19 on oncology practice in Turkey I Beypinar JBUON. 2021; 26 (4): 1659 1662, 2021 | 2 | 2021 |
| Prognostic value of systemic immune index in patients with metastatic gastric cancer H Demir, Y Katırcılar, İ Beypınar, SK Eren, M İnanç European Archives of Medical Research 37 (2), 95-100, 2021 | 2 | 2021 |
| Prognostic impact of prognostic nutritional index and neutrophil/lymphocyte ratio in patients with small-cell lung cancer H Sozel, ISG Beypinar, SS Goksu Eurasian J Medicial Investig 5, 207-12, 2021 | 2 | 2021 |
Mukremin Uysal, MDAntalya Bilim Universityantalya.edu.tr üzerinde doğrulanmış e-posta adresine sahip
